Literature DB >> 8592115

Lipopolysaccharide-enhanced expression of interleukin-6 in dibutyryl cyclic AMP-differentiated rat C6 glioma.

H Slegers1, M Joniau.   

Abstract

Rat C6 glioma synthesizes a low basal level of interleukin-6 (IL-6). Stimulation with 10 micrograms/ml of lipopolysaccharide (LPS) and induction of differentiation with 1 mM N6,O2'-dibutyryl cyclic AMP (dbcAMP) for 48 h increased the secreted activity to 400 and 800 U/ml, respectively. An LPS stimulation of dbcAMP-differentiated cells strongly enhanced the secreted activity. Depending on the dbcAMP concentration, the cell number, and the stimulation time, the secreted IL-6 level increased up to 120,000 U/ml. After 48 h of costimulation with 10 micrograms/ml of LPS and 1 mM dbcAMP, northern blotting and immunoassay demonstrated an eightfold increase in IL-6 mRNA concentration and IL-6 immunoreactivity, whereas titration of the biological activity indicated a 100-fold increase in the secreted IL-6 activity. The enhanced secretion of IL-6 is correlated with the induction of differentiation. Chromatography on heparin-Sepharose and on DEAE-5PW separated the secreted activity into several fractions, indicating that they differ in heparin affinity and charge either by posttranslational modifications or by binding to a carrier protein. Each of the partially purified IL-6-like activities could be neutralized by an anti-murine IL-6 antibody. Our observations demonstrate that in vivo inflammatory signals can trigger astrocytes and their precursors to secrete substantially different levels of immunoregulatory cytokines depending on their degree of differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8592115     DOI: 10.1046/j.1471-4159.1996.66020466.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.

Authors:  P Claes; B Grobben; K Van Kolen; D Roymans; H Slegers
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists.

Authors:  B Grobben; P Claes; D Roymans; E L Esmans; H Van Onckelen; H Slegers
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cells.

Authors:  Minfeng Shu; Yuxi Zhou; Wenbo Zhu; Sihan Wu; Xiaoke Zheng; Guangmei Yan
Journal:  Mol Oncol       Date:  2011-03-21       Impact factor: 6.603

Review 4.  Sphingolipids and cell signalling.

Authors:  P Fredman
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 5.  Image analysis of Ca2+ signals as a basis for neurotoxicity assays: promises and challenges.

Authors:  Rola Barhoumi; Yongchang Qian; Robert C Burghardt; Evelyn Tiffany-Castiglioni
Journal:  Neurotoxicol Teratol       Date:  2009-06-23       Impact factor: 3.763

6.  In vivo effects of Ginkgo biloba extract on interleukin-6 cytokine levels in patients with neurological disorders.

Authors:  Lu Ching-Hsiang; Hwang Chiao-Wen; Chen Nan-Fu; Liu Wen-Sheng; Hsiao Ya-Fen; Wu Wen-Tung
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.